Latest News for Health Catalyst Stock (NASDAQ:HCAT)

Monday, November 13, 2023

Health Catalyst shares are trading higher after Piper Sandler upgraded the stock from Neutral to Overweight.
Benzinga Newsdesk - Nov 13, 2023, 12:04PM
HP To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Monday
Lisa Levin - Nov 13, 2023, 8:32AM
Where Health Catalyst Stands With Analysts
Benzinga Insights - Nov 13, 2023, 7:00AM
Piper Sandler Upgrades Health Catalyst to Overweight, Lowers Price Target to $11
Benzinga Newsdesk - Nov 13, 2023, 4:53AM

Wednesday, November 08, 2023

Outcome Capital Announces Electronic Registry Systems Acquisition By Health Catalyst; No Financial Terms Disclosed
Benzinga Newsdesk - Nov 8, 2023, 11:45AM

Thursday, November 02, 2023

Health Catalyst Q3 EPS $0.03 Beats $(0.02) Estimate, Sales $73.77M Beat $72.66M Estimate
Benzinga Newsdesk - Nov 2, 2023, 5:30PM

Wednesday, November 01, 2023

Stifel Maintains Hold on Health Catalyst, Lowers Price Target to $12
Benzinga Newsdesk - Nov 1, 2023, 3:33PM

Monday, October 30, 2023

RBC Capital Maintains Sector Perform on Health Catalyst, Lowers Price Target to $8
Benzinga Newsdesk - Oct 30, 2023, 1:46PM

Friday, October 27, 2023

Health Catalyst Sees Prelim. Q3 Total Revenue $73.8M vs $72.66M Est.; Sees FY23 Revenue $291M-$296M vs $293.78M Est.
Benzinga Newsdesk - Oct 27, 2023, 8:49AM

Wednesday, October 25, 2023

12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights - Oct 25, 2023, 9:05AM

Monday, October 16, 2023

Alignment Healthcare's Valuation Shows Promise In A Competitive Market: Analyst
Vandana Singh - Oct 16, 2023, 2:36PM

Thursday, September 14, 2023

Cantor Fitzgerald Reiterates Overweight on Health Catalyst, Maintains $16 Price Target
Benzinga Newsdesk - Sep 14, 2023, 11:44AM

Tuesday, August 29, 2023

Canaccord Genuity Maintains Buy on Health Catalyst, Lowers Price Target to $14
Benzinga Newsdesk - Aug 29, 2023, 10:28AM

Tuesday, August 08, 2023

Health Catalyst Q2 Adj EPS $0.05 Up From $(0.03) YoY, Sales $73.21M Beat $72.63M Estimate
Benzinga Newsdesk - Aug 8, 2023, 5:04PM
Earnings Scheduled For August 8, 2023
Benzinga Insights - Aug 8, 2023, 4:48AM

Tuesday, August 01, 2023

Benzinga's Top Ratings Upgrades, Downgrades For August 1, 2023
Benzinga Insights - Aug 1, 2023, 11:00AM
Cantor Fitzgerald Initiates Coverage On Health Catalyst with Overweight Rating, Announces Price Target of $16
Benzinga Newsdesk - Aug 1, 2023, 9:23AM

Tuesday, June 27, 2023

Ohio Health Information Partnership Powers CliniSync With Health Catalyst
Happy Mohamed - Jun 27, 2023, 8:32AM

Wednesday, May 10, 2023

Health Catalyst's Q1 Earnings: Analysts Diverge on Outlook as Company Faces Demand Headwinds and Revenue Outperformance
Vandana Singh - May 10, 2023, 2:33PM
RBC Capital Maintains Sector Perform on Health Catalyst, Lowers Price Target to $13
Benzinga Newsdesk - May 10, 2023, 11:27AM
Benzinga's Top Ratings Upgrades, Downgrades For May 10, 2023
Benzinga Insights - May 10, 2023, 11:00AM
Health Catalyst shares are trading lower after the company reported Q1 financial results and issued guidance.
Benzinga Newsdesk - May 10, 2023, 8:56AM
Raymond James Downgrades Health Catalyst to Market Perform
Benzinga Newsdesk - May 10, 2023, 7:31AM
Guggenheim Downgrades Health Catalyst to Hold
Benzinga Newsdesk - May 10, 2023, 7:06AM

Tuesday, May 09, 2023

Health Catalyst Sees FY23 Revenue $290M-$295M Vs $293.29M Est., Adj. EBITDA $9M-$11M
Benzinga Newsdesk - May 9, 2023, 4:54PM
Health Catalyst Sees Q2 Revenue $70.3M-$74.3M Vs $72.78M Est., Adj. EBITDA $0.75M-$4.75M
Benzinga Newsdesk - May 9, 2023, 4:54PM
Health Catalyst Q1 Adj. EPS $0.05 Beats $(0.04) Estimate, Sales $73.87M Beat $71.24M Estimate
Benzinga Newsdesk - May 9, 2023, 4:53PM
Recap: Health Catalyst Q1 Earnings
Benzinga Insights - May 9, 2023, 4:36PM
Earnings Scheduled For May 9, 2023
Benzinga Insights - May 9, 2023, 6:03AM

Thursday, April 20, 2023

7 Analysts Have This to Say About Health Catalyst
Benzinga Insights - Apr 20, 2023, 5:01PM
Benzinga's Top Ratings Upgrades, Downgrades For April 20, 2023
Benzinga Insights - Apr 20, 2023, 11:00AM

Wednesday, April 05, 2023

Reported Late Tuesday April 4, Health Catalyst Solidifies Multi-Year Partnership With HIE Leader Contexture;
Happy Mohamed - Apr 5, 2023, 12:33AM

Tuesday, April 04, 2023

Health Catalyst shares are trading higher after Wells Fargo upgraded the stock from Equal-Weight to Overweight and raised its price target from $13 to $16.
Benzinga Newsdesk - Apr 4, 2023, 12:57PM
Benzinga's Top Ratings Upgrades, Downgrades For April 4, 2023
Benzinga Insights - Apr 4, 2023, 11:00AM
Wells Fargo Upgrades Health Catalyst to Overweight, Raises Price Target to $16
Benzinga Newsdesk - Apr 4, 2023, 6:13AM

Friday, March 24, 2023

Analyst Expectations for Health Catalyst's Future
Benzinga Insights - Mar 24, 2023, 1:00PM
Citigroup Maintains Buy on Health Catalyst, Lowers Price Target to $16
Benzinga Newsdesk - Mar 24, 2023, 6:39AM

Wednesday, March 08, 2023

Citigroup Maintains Buy on Health Catalyst, Raises Price Target to $17
Benzinga Newsdesk - Mar 8, 2023, 8:27AM

Tuesday, March 07, 2023

Expert Ratings for Health Catalyst
Benzinga Insights - Mar 7, 2023, 10:00AM
Wells Fargo Maintains Equal-Weight on Health Catalyst, Raises Price Target to $13
Benzinga Newsdesk - Mar 7, 2023, 6:10AM

Thursday, March 02, 2023

Raymond James Maintains Strong Buy on Health Catalyst, Raises Price Target to $18
Benzinga Newsdesk - Mar 2, 2023, 8:50AM

Tuesday, February 28, 2023

Health Catalyst Q4 EPS $(0.05) Beats $(0.11) Estimate, Sales $69.16M Beat $68.26M Estimate
Benzinga Newsdesk - Feb 28, 2023, 4:16PM
Earnings Scheduled For February 28, 2023
Benzinga Insights - Feb 28, 2023, 4:34AM

Tuesday, January 03, 2023

Evercore ISI Group Downgrades Health Catalyst to In-Line, Raises Price Target to $11
Benzinga Newsdesk - Jan 3, 2023, 6:55AM

Thursday, November 10, 2022

What 6 Analyst Ratings Have To Say About Health Catalyst
Benzinga Insights - Nov 10, 2022, 12:03PM
Phillips 66 To Rally 25%? Here Are 5 Other Price Target Changes For Thursday
Lisa Levin - Nov 10, 2022, 8:07AM
Analyst Ratings for Health Catalyst
Benzinga Insights - Nov 10, 2022, 8:07AM
Why Merrimack Pharmaceuticals Shares Jumped Around 213%; Here Are 114 Biggest Movers From Yesterday
Lisa Levin - Nov 10, 2022, 5:12AM
Raymond James Maintains Strong Buy on Health Catalyst, Lowers Price Target to $15
Benzinga Newsdesk - Nov 10, 2022, 4:24AM

Wednesday, November 09, 2022

12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga Insights - Nov 9, 2022, 1:44PM

Open7.370	Close7.415
Vol / Avg.228.350K / 461.024K	Mkt Cap426.736M
Day Range7.350 - 7.550	52 Wk Range6.600 - 15.870

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Latest News for Health Catalyst Stock (NASDAQ:HCAT)

Monday, November 13, 2023

Wednesday, November 08, 2023

Thursday, November 02, 2023

Wednesday, November 01, 2023

Monday, October 30, 2023

Friday, October 27, 2023

Wednesday, October 25, 2023

Monday, October 16, 2023

Thursday, September 14, 2023

Tuesday, August 29, 2023

Tuesday, August 08, 2023

Tuesday, August 01, 2023

Tuesday, June 27, 2023

Wednesday, May 10, 2023

Tuesday, May 09, 2023

Thursday, April 20, 2023

Wednesday, April 05, 2023

Tuesday, April 04, 2023

Friday, March 24, 2023

Wednesday, March 08, 2023

Tuesday, March 07, 2023

Thursday, March 02, 2023

Tuesday, February 28, 2023

Tuesday, January 03, 2023

Thursday, November 10, 2022

Wednesday, November 09, 2022